secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zomedica Corp. (ZOMDF)
CIK:        0001684144
Form:       8-K
Filed at:   2023-10-10T23:59:59+00:00
Accession:  0001654954-23-012710
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zomedica acquires Qorvo Biotechnologies, maker of TRUFORMA platform, for undisclosed sum
--------------------------------------------------------------------------------

- Purchase price not disclosed; acquisition includes QBT's manufacturing and R&D staff in Plymouth, MN.
- Deal eliminates future license fees, transition fees, and royalties due to QBT under prior agreement.
- Zomedica assumes QBT's manufacturing line, aiming for margin improvements and accelerated assay development.
- Zomedica updated long-term supply agreement with Qorvo Inc. for BAW sensors.
- Company considering strategic options for human health portion (Omnia platform) to focus on veterinary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1684144/000165495423012710/0001654954-23-012710-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1684144/000165495423012710/zom_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-012710

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer